Novartis reaffirms commitment to fighting malaria and recognizes the dedication of our people and partners.

Volunteerism and giving back to communities where we live and work are more than just tradition; they’re core values.

Novartis is one of 73 companies included in the 2017 Water A List by CDP, the nonprofit global environmental disclosure platform.

The third Novartis Social Business stakeholder dialogue took place on November 21 in Basel.

Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”

Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.

Novartis internships help build research capabilities in developing countries.

Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.